Blood Res.  2022 Mar;57(1):74-75. 10.5045/br.2022.2021146.

COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia

• Kim CS
• Kim JY
• Choi DR

• KMID: 2527500
• DOI: http://doi.org/10.5045/br.2022.2021146

Figure

• 

  Fig. 1 Pneumonia shown on chest radiograph and CT scan taken day 1 was completely gone on radiograph and CT scan taken day 78.

• 

  Fig. 2 Leukocytosis was gone after starting imatinib.

Reference

1. Rea D, Mauro MJ, Cortes JE, et al. 2020; COVID-19 in patients (pts) with chronic myeloid leukemia (CML): results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) study. Blood (ASH Annual Meeting Abstracts). 136(Suppl):46–7. DOI: 10.1182/blood-2020-140161. PMCID: PMC8330226.

2. Foà R, Bonifacio M, Chiaretti S, et al. 2020; Philadelphia-positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID-19 pandemic: a Campus ALL study. Br J Haematol. 190:e3–5. DOI: 10.1111/bjh.16758. PMCID: PMC7267647. PMID: 32368790.

3. Breccia M, Abruzzese E, Bocchia M, et al. 2020; Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey. Leukemia. 34:2260–1. DOI: 10.1038/s41375-020-0904-z. PMID: 32555369. PMCID: PMC7301058.

4. Coleman CM, Sisk JM, Mingo RM, Nelson EA, White JM, Frieman MB. 2016; Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion. J Virol. 90:8924–33. DOI: 10.1128/JVI.01429-16. PMID: 27466418. PMCID: PMC5021412.

5. Galimberti S, Petrini M, Baratè C, et al. 2020; Tyrosine kinase inhibitors play an antiviral action in patients affected by chronic myeloid leukemia: a possible model supporting their use in the fight against SARS-CoV-2. Front Oncol. 10:1428. DOI: 10.3389/fonc.2020.01428. PMID: 33014780. PMCID: PMC7493657. PMID: 008940af48964fb69bb44c865433b1e1.

6. Ector GICG, Huijskens EGW, Blijlevens NMA, Westerweel PE. 2020; Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study. Leukemia. 34:2533–5. DOI: 10.1038/s41375-020-0964-0. PMID: 32641732. PMCID: PMC7341464.

7. EHA Scientific Working Group. 2020. CML, TKI treatment and COVID-19 disease. iCMLf;Bexhill, UK: https://www.cml-foundation.org/news-icmlf-mobile/1452-cml-tki-treatment-and-covid-19-disease.html. Accessed November 18, 2021.

8. Yılmaz U, Pekmezci A, Gül Y, Eşkazan AE. 2021; COVID-19 in chronic-phase chronic myeloid leukemia patients: a single-center survey from Turkey. Turk J Haematol. 38:79–81. DOI: 10.4274/tjh.galenos.2020.2020.0472. PMID: 32964857. PMCID: PMC7927441.